{
    "Trade/Device Name(s)": [
        "Audit\u00ae MicroCV\u2122 Beta-Hydroxybutyric Acid Linearity Set"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K130157",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101427"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "March 19, 2013",
    "Summary Letter Received Date": "February 06, 2013",
    "Submission Date": "January 14, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Beta-Hydroxybutyric Acid"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u00ae MicroCV\u2122 Beta-Hydroxybutyric Acid Linearity Set as an assayed human serum quality control material for linearity assessment.",
    "Indications for Use Summary": "Intended to simulate human serum for determining linearity, calibration verification, and reportable range for Beta-Hydroxybutyric Acid in quantitative assays, for in vitro diagnostic use only.",
    "fda_folder": "Clinical Chemistry"
}